News Conference News TCT 2017 Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock Yael L. Maxwell November 09, 2017
Presentation TCT 2017 Point A Multi-Device Lesion-Specific Approach is Preferred! Presenter: Michael J. Reardon November 01, 2017
Presentation TCT 2017 The Compelling Saga of Stroke after TAVR: Key Messages From NeuroARC Presenter: Michael J. Reardon, Didier Tchetche, Alexandra J. Lansky October 31, 2017
Presentation TCT 2017 LOTUS TAVR Technology Review (Including EDGE) and Clinical Program Updates Presenter: Michael J. Reardon October 31, 2017
Presentation TCT 2017 Viewpoint #1: PARTNER 2A and SURTAVI are Convincing TAVR is Preferred in ALL (Appropriate) Intermediate-Risk Patients Presenter: Michael J. Reardon October 30, 2017